[HTML][HTML] Liposomes: structure, biomedical applications, and stability parameters with emphasis on cholesterol

P Nakhaei, R Margiana, DO Bokov… - … in bioengineering and …, 2021 - ncbi.nlm.nih.gov
Liposomes are essentially a subtype of nanoparticles comprising a hydrophobic tail and a
hydrophilic head constituting a phospholipid membrane. The spherical or multilayered …

[HTML][HTML] Recent advances in polysaccharides based biomaterials for drug delivery and tissue engineering applications

A Sood, A Gupta, G Agrawal - Carbohydrate Polymer Technologies and …, 2021 - Elsevier
In this paper, a spotlight is shown on polysaccharides based biomaterials which have
surfaced as a versatile platform for different biomedical applications including drug delivery …

[HTML][HTML] Functionalized liposomes for targeted breast cancer drug delivery

J Nel, K Elkhoury, É Velot, A Bianchi, S Acherar… - Bioactive materials, 2023 - Elsevier
Despite the exceptional progress in breast cancer pathogenesis, prognosis, diagnosis, and
treatment strategies, it remains a prominent cause of female mortality worldwide …

[HTML][HTML] Polymeric particle-based therapies for acute inflammatory diseases

ER Brannon, MV Guevara, NJ Pacifici, JK Lee… - Nature Reviews …, 2022 - nature.com
Acute inflammation is essential for initiating and coordinating the body's response to injuries
and infections. However, in acute inflammatory diseases, inflammation is not resolved but …

Targeted liposomal drug delivery: a nanoscience and biophysical perspective

Y Liu, KMC Bravo, J Liu - Nanoscale Horizons, 2021 - pubs.rsc.org
Liposomes are a unique platform for drug delivery, and a number of liposomal formulations
have already been commercialized. Doxil is a representative example, which uses …

Walking dead tumor cells for targeted drug delivery against lung metastasis of triple‐negative breast cancer

Z Zhao, L Fang, P Xiao, X Sun, L Zhou, X Liu… - Advanced …, 2022 - Wiley Online Library
Lung metastasis is challenging in patients with triple‐negative breast cancer (TNBC).
Surgery is always not available due to the dissemination of metastatic foci and most drugs …

[HTML][HTML] Liposomes in cancer therapy: how did we start and where are we now

MD Fulton, W Najahi-Missaoui - International Journal of Molecular …, 2023 - mdpi.com
Since their first discovery in the 1960s by Alec Bangham, liposomes have been shown to be
effective drug delivery systems for treating various cancers. Several liposome-based …

Exosomes as a next-generation drug delivery system: An update on drug loading approaches, characterization, and clinical application challenges

F Mehryab, S Rabbani, S Shahhosseini, F Shekari… - Acta biomaterialia, 2020 - Elsevier
Exosomes are small nanoparticles secreted by almost all cells and have a well-known role
in intercellular communication. They are found in different body fluids and can also be …

Immunogenic hybrid nanovesicles of liposomes and tumor-derived nanovesicles for cancer immunochemotherapy

M Hu, J Zhang, L Kong, Y Yu, Q Hu, T Yang, Y Wang… - Acs Nano, 2021 - ACS Publications
Exploring a rational delivery system of integrating chemotherapy with immunotherapy to
broaden benefits of cancer immunochemotherapy is still under challenge. Herein, we …

Temperature treatment of highly porous zirconium-containing metal–organic frameworks extends drug delivery release

MH Teplensky, M Fantham, P Li, TC Wang… - Journal of the …, 2017 - ACS Publications
Utilizing metal–organic frameworks (MOFs) as a biological carrier can lower the amount of
the active pharmaceutical ingredient (API) required in cancer treatments to provide a more …